BULLFROG AI HOLDINGS INC. news, videos and press releases
For more news please use our advanced search feature.
BULLFROG AI HOLDINGS INC. - More news...
BULLFROG AI HOLDINGS INC. - More news...
- BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial
- BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week
- BullFrog AI Issues Letter to Stockholders
- BullFrog AI Announces Appointment of Chief Financial Officer
- BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium
- Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
- Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
- BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni
- BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114
- BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
- BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets
- Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12
- BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
- BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
- BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
- BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
- BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock
- BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
- BullFrog AI Announces Closing of $5.7 Million Public Offering
- Bullfrog AI Announces Pricing of $5.7 Million Public Offering
- BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
- BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data
- BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
- BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17
- BullFrog AI Issues Letter to Shareholders
- BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity
- BullFrog AI to Present at Benzinga All Access Event on October 20
- BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
- BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma
- BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023
